Diagnostic utility of targeted next-generation sequencing in indeterminate pancreaticobiliary cytology and small biopsy specimens: a prospective cohort study
Open Access
- 30 April 2026
- journal article
- research article
- Published by Springer Nature in Virchows Archiv
- p. 1-9
Abstract
Pancreaticobiliary cytology is a highly specific but variably and often insufficiently sensitive diagnostic method. This study evaluated the utility of next-generation sequencing (NGS) in difficult-to-classify pancreaticobiliary specimens. A total of 136 patients were prospectively included, with cytology or small biopsy specimens from the pancreas ( n = 74), extrahepatic biliary tree ( n = 56), pancreatic duct ( n = 4), gallbladder ( n = 1), and peripancreatic lymph node ( n = 1). All cases were diagnosed by cytopathologists with expertise in pancreaticobiliary (cyto)pathology using 2022 WHO Reporting System for Pancreaticobiliary Cytopathology. Large scale pan-cancer panel was used for NGS testing. Forty-five cases (33,1%) were non-analyzable by NGS, and no genetic changes were found in 21 cases (23,1% of analyzable cases). Separate acquisition and storage of cytology/biopsy materials in RNAlater solution significantly decreased the rate of non-analyzable samples (23.3% versus 44.4%; Fisher’s exact test: p = 0.0108, OR = 0.379, 95% CI 0.182–0.792). Diagnostic genetic alterations were identified in 70/91 of analyzable cases (76.9%). Suspicion was raised for the presence of germline mutation in 10 patients. Potentially druggable alterations ( n = 42) were found in 36/91 patients (39,5%), including mutations in homologous recombination genes, PI3K/AKT/mTOR pathway, Cyclin D1-CDK4/6-Rb pathway, and potentially targetable KRAS mutations ( KRAS G12D mutation occurred in 19/41 [46,3%] of KRAS -mutated tumors). Supplementing pancreaticobiliary (cyto)pathology with information from NGS increased the sensitivity for tumor diagnosis from 35.9% to 86.6% (with specificity 100%), improved negative predictive value from 14.2% to 41.2%, and enhanced overall diagnostic accuracy from 42.1% to 87.8%, respectively. In challenging cases, NGS significantly improves preoperative pancreaticobiliary diagnosis and informs clinical decision-making.Keywords
Funding Information
- Univerzita Karlova v Praze
This publication has 52 references indexed in Scilit:
- FISHing for pancreatobiliary tract malignancy in endoscopic brushings enhances the sensitivity of routine cytologyCytopathology, 2014
- Endoscopic ultrasound guided fine needle aspiration with fluorescence in situ hybridization analysis in 104 patients with pancreatic massJournal of Gastroenterology and Hepatology, 2014
- Targeted next‐generation sequencing of cancer genes dissects the molecular profiles of intraductal papillary neoplasms of the pancreasThe Journal of Pathology, 2014
- Significance of atypia in pancreatic and bile duct brushings: Follow‐Up analysis of the categories atypical and suspicious for malignancyDiagnostic Cytopathology, 2013
- Sensitivity of endoscopic retrograde cholangiopancreatography standard cytology: 10-y review of the literatureJournal of Surgical Research, 2013
- Diagnostic accuracy of conventional and cholangioscopy-guided sampling of indeterminate biliary lesions at the time of ERCP: a prospective, long-term follow-up studyGastrointestinal Endoscopy, 2012
- EUS-FNA with rescue fluorescence in situ hybridization for the diagnosis of pancreatic carcinoma in patients with inconclusive on-site cytopathology resultsGastrointestinal Endoscopy, 2011
- Preoperative Factors Predict Perioperative Morbidity and Mortality After PancreaticoduodenectomyAnnals of Surgical Oncology, 2011
- Comparison of KRAS Mutation Analysis and FISH for Detecting Pancreatobiliary Tract Cancer in Cytology Specimens Collected During Endoscopic Retrograde CholangiopancreatographyThe Journal of Molecular Diagnostics, 2010
- Pancreatic and bile duct brushing cytology in 1000 casesCancer, 2006